Did you know that peripheral arterial disease (PAD) is asymptomatic in 50-75% of cases(1)? This is an alarming statistic, especially when we consider that PAD is a strong risk factor for cardiovascular disease (the leading cause of death worldwide).
Considering also that 25% of cases of sudden cardiac death have no prior symptoms or appreciable risk factors(2), the need for early detection of PAD becomes clear.
As well as its link to mortality, PAD is a leading cause of morbidity - PAD can lead to foot ulceration, which can lead to amputation - with devastating physical and emotional impacts on the individual as well as significant financial implications for the health system.
Currently, PAD is underdiagnosed, hence undertreated(3). There is a compelling need for more targeted screening in at-risk populations to reduce morbidity and mortality rates in people with PAD.
One of the reasons for underdiagnosis is inadequate screening due to a lack of knowledge among Health Professionals of which assessments are most effective in making a diagnosis of PAD. Commonly used tests for PAD have limited sensitivity in the most at-risk populations (4). Clinical assessments range from simple observation to more complex ABI (ankle-brachial index). Research supports the use of some, but not all of these assessment techniques. Below are some of the most common:
Another barrier to effective screening is that certain guidelines don’t reflect the latest evidence.
With all this in mind, I’m sure you’re keen to learn more. Join us on Monday, August 6th at 7.30PM (AEST) for a one-hour webinar, where our expert presenter Dr Sylvia McAra will share a best-practice approach to assessing PAD using evidence-based clinical tests.
This is a multidisciplinary webinar for Podiatrist, GPs and Nurses. Click here to read more and enrol.
References:
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreAn increasing number of pregnant patients are seeking advice from their GP about prenatal genetic testing. This FastTrack covers non-invasive prenatal testing/screening, including how it works, indications, limitations, and different types of testing panels. 30mins each of RP and EA CPD available.
Wearables with PPG or ECG capabilities can identify episodes of irregular heart rhythms suggestive of AF, but should not replace traditional methods of diagnosis, such as a 12-lead ECG. Evidence of accuracy and positive predictive values from prospective, comparative trials involving older populations are limited, and the potential for inconclusive results remains a concern based on current trial findings. Their utility may be highest for symptomatic individuals or those at risk of developing AF.
Reproductive genetic carrier screening (RGCS) may be considered for patients during their preconception counselling stage. This FastTrack covers who should be offered RGCS, which conditions it screens for, and what to do with the results. 30mins each of RP and EA CPD available.